Search

Search results

10 results found

Targeting CD73 and correcting adenosinergic signaling in critically ill patients.

Publication: Journal Article

Lunderberg, Justin Mark, Alexander James Spicer, Jessica Cassavaugh, Juho Jalkanen, György Haskó, and Simon C Robson. 2025. “Targeting CD73 and Correcting Adenosinergic Signaling in Critically Ill Patients.”. Frontiers in Pharmacology 16: 1601481.

CD39 regulates P2RX7-mediated lung necrotic lesions in severe experimental tuberculosis.

Publication: Journal Article

Almeida-Santos, Gislane, Igor Santiago-Carvalho, Fabrício Moreira Almeida, Caio César Barbosa Bomfim, Juan Carlo Santos E Silva, Deborah Giovanna Cantarini, Camila Ramos Silva, et al. 2026. “CD39 Regulates P2RX7-Mediated Lung Necrotic Lesions in Severe Experimental Tuberculosis.”. Mucosal Immunology.

Purinergic signal transduction and metabolic regulation by ENTPD5 and ENTPD6.

Publication: Journal Article

Qi, Yihang, Xuefei Li, Xinyu Song, Wenyi Wei, Ionita Ghiran, and Simon C Robson. 2026. “Purinergic Signal Transduction and Metabolic Regulation by ENTPD5 and ENTPD6.”. Frontiers in Endocrinology 17: 1680378.

AI-Guided Additive Scoring Model for Differential Diagnosis of Primary Liver Cancer.

Publication: Journal Article

Salzmann, Rebekka J S, Tudor Mocan, Arnulf G Willms, Angelina Klein, Robert Schwab, Emil Mois, Cristiana Grapa, et al. 2026. “AI-Guided Additive Scoring Model for Differential Diagnosis of Primary Liver Cancer.”. JHEP Reports : Innovation in Hepatology, 101826.

Dysregulation of CD39/Ectonucleoside Triphosphate Diphosphohydrolase 1 Causes Urinary Bladder Dysfunction with Abnormal Smooth Muscle Contractility.

Publication: Journal Article

Luo, Zhaobo, Huan Chen, Ali Wu, Weipu Mao, Sagar Barge, Seth L Alper, Simon C Robson, and Weiqun Yu. 2026. “Dysregulation of CD39/Ectonucleoside Triphosphate Diphosphohydrolase 1 Causes Urinary Bladder Dysfunction With Abnormal Smooth Muscle Contractility.”. FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology 40 (7): e71735.

In tribute to Francesco Di Virgilio, a great scientist and a wonderful friend.

Publication: Journal Article

Falzoni, Simonetta, Anna Lisa Giuliani, Elena Adinolfi, Robson Coutinho-Silva, Peter Illes, Simon C Robson, Yong Tang, Henning Ulrich, and Charles Kennedy. 2026. “In Tribute to Francesco Di Virgilio, a Great Scientist and a Wonderful Friend.”. Purinergic Signalling 22 (1): 20.

Metabolic reprogramming and intracellular ATP homeostasis in immunity.

Publication: Journal Article

Antonioli, Luca, Giulia Valdiserra, Pál Pacher, Simon C Robson, and György Haskó. 2026. “Metabolic Reprogramming and Intracellular ATP Homeostasis in Immunity.”. Pharmacology & Therapeutics 281: 109011.

Dr. Somnath Bose publishes study identifying priorities of patients who survive an Intensive Care unit stay

News: January 01, 2026

Surviving ICU stay is often just the first step in a long road to recovery for most. The aftermath of critical illness is often challenging for survivors and their caregivers who bear the burden of post-intensive care syndrome (PICS). Unfortunately, there is very little investigation on how...

Immune biomarkers predicting response to G-CSF in acute-on-chronic liver failure: results from a GRAFT trial sub-study.

Publication: Journal Article

Splith, Katrin, Nadja Berndt, Philipp K Haber, Simon Wabitsch, Linda Feldbrügge, Adam Herber, Annegret Franke, et al. 2026. “Immune Biomarkers Predicting Response to G-CSF in Acute-on-Chronic Liver Failure: Results from a GRAFT Trial Sub-Study.”. Hepatology International.

Targeting CD39 in combination with IL-2/anti-IL-2 complexes enhances cytotoxic immunity and limits tumor progression.

Publication: Journal Article

Abrate, Carolina, Valentina Brunotto, Sabrina N Bossio, Santiago Boccardo, Jimena Tosello Boari, Pamela Caudana, Lara Hernandez, et al. 2026. “Targeting CD39 in Combination With IL-2/Anti-IL-2 Complexes Enhances Cytotoxic Immunity and Limits Tumor Progression.”. Frontiers in Immunology 17: 1730342.